Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

C. M. Sloan; L. J. Sherrard; G. G. Einarsson; M. M. Tunney; D. G. Downey

doi:10.1016/S1569-1993(21)01175-9

Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

C. M. Sloan, L. J. Sherrard, G. G. Einarsson, M. M. Tunney, D. G. Downey

Research output: Contribution to journal › Meeting abstract › peer-review

Original language	English
Article number	P149
Pages (from-to)	S84-S85
Journal	Journal of Cystic Fibrosis
Volume	20
Issue number	Supplement 1
DOIs	https://doi.org/10.1016/S1569-1993(21)01175-9
Publication status	Published - 01 Jun 2021
Event	44th European Cystic Fibrosis Conference 2021 - virtual, online Duration: 09 Jun 2021 → 12 Jun 2021 https://www.ecfs.eu/digital2021

Access to Document

10.1016/S1569-1993(21)01175-9Licence: Unspecified

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance
Sloan, C. M. (Author), Downey, D. (Supervisor) & Sherrard, L. (Supervisor), Dec 2024
Student thesis: Doctoral Thesis › Doctor of Philosophy

Cite this

@article{bc00e7f6a7ed41d4b242444cfdfa64b6,

title = "Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis",

author = "Sloan, {C. M.} and Sherrard, {L. J.} and Einarsson, {G. G.} and Tunney, {M. M.} and Downey, {D. G.}",

year = "2021",

month = jun,

day = "1",

doi = "10.1016/S1569-1993(21)01175-9",

language = "English",

volume = "20",

pages = "S84--S85",

journal = "Journal of Cystic Fibrosis",

issn = "1569-1993",

publisher = "Elsevier B.V.",

number = "Supplement 1",

note = "44th European Cystic Fibrosis Conference 2021 ; Conference date: 09-06-2021 Through 12-06-2021",

url = "https://www.ecfs.eu/digital2021",

}

TY - JOUR

T1 - Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

AU - Sloan, C. M.

AU - Sherrard, L. J.

AU - Einarsson, G. G.

AU - Tunney, M. M.

AU - Downey, D. G.

PY - 2021/6/1

Y1 - 2021/6/1

U2 - 10.1016/S1569-1993(21)01175-9

DO - 10.1016/S1569-1993(21)01175-9

M3 - Meeting abstract

SN - 1569-1993

VL - 20

SP - S84-S85

JO - Journal of Cystic Fibrosis

JF - Journal of Cystic Fibrosis

IS - Supplement 1

M1 - P149

T2 - 44th European Cystic Fibrosis Conference 2021

Y2 - 9 June 2021 through 12 June 2021

ER -

Evolution of levofloxacin resistance and phenotypic characterisation of Pseudomonas aeruginosa clinical isolates from people with cystic fibrosis

Access to Document

Student theses

Levofloxacin: reducing the risk of Pseudomonas aeruginosa resistance

Cite this